Remission in rheumatoid arthritis: is it all the same? - PubMed (original) (raw)

Review

Remission in rheumatoid arthritis: is it all the same?

Hanna L Gul et al. Expert Rev Clin Pharmacol. 2015.

Abstract

Remission is the key treatment goal in rheumatoid arthritis and should provide the optimal state for patients. Clinical remission criteria are based on composite scores of disease activity and are widely used in clinical practice and trials. With the use of biologic therapies and treat to target strategies, rates of clinical remission have significantly improved. Despite achieving this target, many patients demonstrate structural and functional deterioration. This raises the question regarding the validity of clinical criteria, although they have evolved significantly over the years. Imaging modalities such as ultrasound have been described as more accurate methods of assessing the remission state compared with clinical assessment alone. Furthermore, immuno-pathological assessments are gaining significant interest as this would enable assessment of disease activity at the primary site of pathology. Further research is required to develop accurate biomarkers of remission. We aimed to review the evolution of remission criteria in rheumatoid arthritis to date and to evaluate novel concepts in and the future of defining remission.

Keywords: T-cell immunology; biomarkers; classification criteria; comprehensive disease control; disease-modifying anti-rheumatic drugs; remission; rheumatoid arthritis; ultrasound.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources